Navigation Links
Breast cancer survivors slacken on mandated annual mammograms

According to a new study, breast cancer survivors who are at a high risk of a relapse or cancer of the other breast should ideally be getting an annual screening// or mammogram done. But the study has found a decline in the annual follow-up trend especially during the five year period after the cancer. During a five-year period, the study showed that only one in three women, in the risk category, had actually undergone annual mammograms.

According to statistics, nearly 2.3 million women in the United States have received treatment for breast cancer. The risk for a woman, who has already suffered breast cancer, is almost 3 times enhanced to suffer a malignancy in the other breast. An annual follow up is a must which can help in early identification of any subsequent cancers.

The researchers found that in the first year after treatment, 80 percent of women had received a screening mammogram. At the fifth year of follow-up, only 63 percent had received a mammogram that year, and only one in three women (33 percent) had received a mammogram each year over the five years.

The study has clearly established that regular mammography for breast cancer survivors have shown a downward trend. The authors say 'Efforts are needed to increase awareness among healthcare providers and breast cancer survivors on the value of follow-up mammography.'

This study has been published in the June 1, 2006 issue of CANCER, a journal of the American Cancer Society.
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... ... Today, Our Urgent Care celebrates the grand opening of its newest urgent ... opening over a month ago, Our Urgent Care Washington has enjoyed serving Franklin County ... Care walk-in clinic is located at 3195 Phoenix Center Dr., Washington, MO 63090 in ...
(Date:5/22/2017)... ... 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” tells the story in ... Rodriguez takes readers on a rollercoaster ride that includes a midnight trek to the ... a dark place where Donald considers suicide. Readers learn how Donald finally achieves ...
(Date:5/22/2017)... , ... May 22, 2017 , ... Faithfully following pop ... body squatted, stretched, jumped, toned and shaped through fitness programs. It carries on to ... course, finished off with an irresistible, radiant smile. CDA has found that ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... a larger group investing in InsightRX, an early stage company in San Francisco ... and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as the lead ...
(Date:5/21/2017)... Texas (PRWEB) , ... May 19, 2017 , ... ... is pleased to announce the appointment of James (Jim) Vertino as Chief Information ... is a proven, transformational leader who drives innovation and business performance. He defines ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... BARRINGTON, Ill. , May 10, 2017 ... medicine today; unfortunately its costs have also spiraled to ... are being sent to radiology than ever before as ... and diagnosis.  For a patient with lower back pain ... prove no anatomical reason for pain, resulting in entirely ...
(Date:5/9/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... has earned a spot on Forbes, "America,s ... ranked among 500 U.S. employers as well as in ... Services. The annual Forbes rankings ... of over 30,000 employees across 25 industries. The survey ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
Breaking Medicine Technology: